qHTS for compounds that Interfere with AlphaLISA Technology

Research project

Description

Project highlights: assay has been miniaturized and is HTS ready. During this period, the NCGC has fostered and maintained over 180 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to over 100 high-throughput screens and nearly 60 medicinal chemistry campaigns, providing our collaborators and the general research community a wealth of publications and promising small molecule leads. In addition, the NCGC has undertaken a number of informatic challenges to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
StatusFinished
Effective start/end date9/30/066/30/16

Funding

  • National Institutes of Health
  • National Institutes of Health: $7,199,169.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $6,630,454.00

Fingerprint

Translational Medical Research
Research
Informatics
Pharmaceutical Chemistry
Drug Discovery
Publications
Research Personnel
Pharmaceutical Preparations
Health
Organized Financing

Keywords

  • Medicine(all)